VERA — Vera Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Vera Therapeutics Appoints Christopher Hite To Board Of Directors
Vera Therapeutics' 2025 net loss wider than expectations
U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's
U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods
Vera soars as FDA accepts priority review for kidney disease drug
Brief: Vera Therapeutics Announces U.S. FDA Granted Priority Review To Biologics License Application
U.S. RESEARCH ROUNDUP-Comerica, Heico, Walmart
Brief: Vera Therapeutics Prices Public Offering Of Class A Common Stock At $42.50 Per Share
Brief: Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers To Its Board Of Directors
Brief: Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Vera Therapeutics Announces Positive Origin Phase 3 Data For Atacicept In IGA Nephropathy
Vera Therapeutics Q3 EPS misses estimates
Brief: Vera Therapeutics Q3 EPS USD -1.26 Vs. IBES Estimate USD -1.17
Brief: Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Vera Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Vera Therapeutics Files For Offering Of Up To $200 Million Class A Common Stock - Filing
Vera Therapeutics Q2 net loss widens
Brief: Vera Therapeutics reports inducement grants under Nasdaq listing rule